DrugPatentWatch Database Preview
Adapt Company Profile
What is the competitive landscape for ADAPT, and when can generic versions of ADAPT drugs launch?
ADAPT has two approved drugs.
There are eight US patents protecting ADAPT drugs.
There are fifteen patent family members on ADAPT drugs in twelve countries and one supplementary protection certificate in one country.
Summary for Adapt
| International Patents: | 15 |
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
| Patent Litigation for Adapt: | See patent lawsuits for Adapt |
Drugs and US Patents for Adapt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adapt | NARCAN | naloxone hydrochloride | SPRAY, METERED;NASAL | 208411-001 | Nov 18, 2015 | RX | Yes | Yes | 9,561,177 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Adapt | NARCAN | naloxone hydrochloride | SPRAY, METERED;NASAL | 208411-001 | Nov 18, 2015 | RX | Yes | Yes | 9,775,838 | ➤ Sign Up | ➤ Sign Up | ||||
| Adapt | NARCAN | naloxone hydrochloride | INJECTABLE;INJECTION | 016636-003 | Jun 14, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Adapt | NARCAN | naloxone hydrochloride | SPRAY, METERED;NASAL | 208411-001 | Nov 18, 2015 | RX | Yes | Yes | 10,085,937 | ➤ Sign Up | ➤ Sign Up | ||||
| Adapt | NARCAN | naloxone hydrochloride | INJECTABLE;INJECTION | 016636-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Adapt | NARCAN | naloxone hydrochloride | SPRAY, METERED;NASAL | 208411-001 | Nov 18, 2015 | RX | Yes | Yes | 9,211,253 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Adapt | NARCAN | naloxone hydrochloride | SPRAY, METERED;NASAL | 208411-002 | Jan 24, 2017 | DISCN | Yes | No | 9,707,226 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ADAPT drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Nasal Spray | 4 mg/spray | ➤ Subscribe | 2016-07-15 |
International Patents for Adapt Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| United Kingdom | 201616616 | ➤ Sign Up |
| Spain | 2631504 | ➤ Sign Up |
| Japan | 2017508800 | ➤ Sign Up |
| European Patent Office | 3116478 | ➤ Sign Up |
| Mexico | 2016011902 | ➤ Sign Up |
| Canada | 2942611 | ➤ Sign Up |
| Germany | 112015001251 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Adapt Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 292 | Luxembourg | ➤ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
